preprint · medRxiv
Abstract Background Sickle cell anaemia (SCA) is characterised by chronic haemolysis, inflammation, platelet activation, and recurrent vaso-occlusive complications. Mean platelet volume (MPV) is a readily available platelet index, but evidence regarding its relationship with disease severity in paediatric SCA remains limited and inconsistent, particularly in African populations. Objective To evaluate the relationship between MPV and disease severity among children with SCA in Kwara State, North-Central Nigeria. Methods This hospital-based cross-sectional study included 51 clinically stable children with confirmed SCA consecutively recruited from the paediatric haematology clinic of Children Emergency Specialist Hospital, Ilorin. Complete blood count, including MPV, was performed using a Rayto RT-7600 automated haematology analyser. Disease severity was assessed using a composite clinical and laboratory scoring system based on a previously described method. Pearson’s correlation, Spearman’s rank correlation, simple linear regression, and the Kruskal–Wallis test were used as appropriate. Statistical significance was set at p < 0.05. Results Of 51 participants, 14 (27.5%) had mild, 33 (64.7%) moderate, and 4 (7.8%) severe disease. Mean MPV was 9.34 ± 0.76 fL (range, 8.0–11.2). Pearson’s correlation showed a weak positive, non-significant linear relationship with severity score (r = 0.231, p = 0.103), whereas Spearman’s analysis showed a weak positive monotonic association (ρ = 0.286, p = 0.042). Regression explained 5.3% of severity-score variation (R² = 0.053, p = 0.103). MPV did not differ significantly across severity categories (H = 2.163, p = 0.339). MPV correlated inversely with haemoglobin (r = −0.556, p < 0.001) and positively with platelet count (r = 0.307, p = 0.029). Conclusion MPV showed a weak relationship with disease severity but inconsistent statistical evidence across analyses. The limited explained variance and absence of significant differences between severity categories do not support MPV as a standalone severity marker. Larger longitudinal studies are warranted.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.64898/2026.08.28.26361349
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.